Risk for uveitis relapse after COVID-19 vaccination.

ABSTRACT:

Objectives

Several studies suggested that coronavirus disease 2019 (COVID-19) vaccination may lead to uveitis, a vision-threatening condition often associated with a variety of autoimmune or autoinflammatory diseases. This study aims to explore factors that influence the risk of uveitis relapse after COVID-19 vaccination to guide the prevention of disease.

Methods

Uveitis relapse was evidenced by worsening activity of intraocular inflammation (e.g. anterior chamber cells, vitreous haze) as defined by the Standardization of Uveitis Nomenclature Working Group. Time to uveitis relapse since the administration of each dose of COVID-19 vaccine was compared across participants with modifiable variables.

Results

The primary analysis included 438 non-COVID-19 participants wit

SUBMITTER: Zhong Z 

PROVIDER: S-EPMC9531657 | biostudies-literature | 2022 Dec

REPOSITORIES: biostudies-literature